Changes in cholecystokinin mRNA expression after amygdala kindled seizures: An in situ hybridization study

Molecular Brain Research

Volumn 35, Issue 1-2, 1996, Pages 278-284

  Zhang, Li Xin ^a   Smith, Mark A ^a   Kim, Su Yong ^a   Rosen, Jeffrey B ^a   Weiss, Susan R B ^a   Post, Robert M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cholecystokinin; Electroconvulsive seizure; In situ hybridization; Kindling; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; CHOLECYSTOKININ; MESSENGER RNA; NEUROPEPTIDE;

ADAPTATION; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DENTATE GYRUS; ELECTROSTIMULATION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; INTERNEURON; KINDLING; MALE; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SEIZURE;

ANIMALIA;

EID: 0030043999     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(95)00230-P     Document Type: Article

References (35)

1. Cain, D.P. and Corcoran, M.E., Epileptiform effects of met-enkephalin, beta-endorphin and morphine: kindling of generalized seizures and potentiation of epileptiform effects by handling, Brain Res., 338 (1985) 327-336.
2. Deschenes, R.J., Lorenz, L.J., Haun, R.S., Roos, B.A., Collier, K.J. and Dixon, J.E., Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin, Proc. Natl. Acad. Sci. USA, 81 (1984) 726-730.
3. Elazar, Z., Motles, E., Ely, Y. and Simanto, R., Acute tolerance to the excitatory effect of enkephalin microinjections into hippocampus, Life Sci., 24 (1979) 541-548.
4. Faris, P., Komisuruk, B., Watkins, L. and Mayer, D., Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia, Science, 219 (1983) 310-312.
5. Gall, C., Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers, J. Neurosci., 8 (1988) 1852-1862.
6. Greenwood, R.S., Godar, S.E. and Hayward, J.N., Cholecystokinin in Hippocampal pathways, J. Comp. Neurol., 203 (1981) 335-350.
7. Gruber, B., Greber, S. and Sperk, G., Kainic acid seizures cause enhanced expression of cholecystokinin-octapeptide in the cortex and hippocampus of the rat, Synapse, 15 (1993) 221-228.
8. Han, J.S., Ding, X.Z. and Fan, S.G., Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substance?, Neuropeptides, 5 (1985) 399-402.
9. Harris, Q.L., Lewis, S.J., Shulkes, A., Vajda, F.J. and Jarrott, B., Regional brain concentrations of cholecystokinin in the rat: the effects of kindled and non-kindled seizures, Neuropharmacology, 27 (1988) 547-550.
10. Iadarola, M.J., Shin, C., McNamara, J.O. and Yang, H.Y., Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling, Brain Res., 365 (1986) 185-191.
11. Innis, R.B., Correa, F.M.A., Uhl, G.R., Schneider, B. and Snyer, S.H., Cholecystokinin octapeptide immunoreactivity. Histochemical localization in rat brain, Proc. Natl Acad. Sci. USA, 76 (1979) 521-525.
12. Jacobs, O., Van Bree, L., Mailleux, P., Zhang, F., Schiffmann, S., Halleux, P., Albala, N. and Vanderhaeghen, J., Homolateral cerebrocortical increase of immediate early gene and neurotransmitter messenger RNAs after minimal cortical lesion: blockade by N-methyl-D-aspartate antagonist, Neuroscience, 59 (1994) 827-836.
13. Kadar, T., Borda, L., Zarandi, M., Penke, B., Kovacs, K. and Telegdy, G., Inhibition of electroshock-induced seizures by cholecystokinin-related peptides in mice, Acta Physiol. Hung., 69 (1987) 43-50.
14. Kadar, T., Pesti, A. and Peuke, B., Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptide and their fragments in rats after intracerebroventricular administration, Neuropharmacology, 23 (1984) 955-961.
15. Kraus, J.E., Yeh, G.C., Bonhaus, D.W., Nadler, J.V. and McNamara, J.O., Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3, J. Neurosci., 14 (1994) 4196-4205.
16. Meyer, D.K., Widmann, R. and Sperk, G., Increased brain levels of cholecystokinin octapeptide after kainic acid-induced seizures in the rat, Neurosci. Lett., 69 (1986) 208-211.
17. Olenik, C., Meyer, D.K., Marksteiner, J. and Sperk, G., Concentrations of mRNAs encoding for preprosomatostatin and preprocholecystokinin are increased after kainic acid-induced seizures, Synapse, 4 (1989) 223-228.
18. Orzi, F., Zoli, M., Passarelli, F., Ferraguti, F., Fieschi, C. and Agnati, L.F., Repeated electroconvulsive shock increases glial fibrillary acidic protein, ornithine decarboxylase, somatostatin and cholecystokinin immunoreactivities in the hippocampal formation of the rat, Brain Res., 533 (1990) 223-231.
19. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd Edn., Academic Press, Sydney, 1986.
20. Post, R.M., Putnam, F., Contel, N.R. and Goldman B., Electroconvulsive seizures inhibit amygdala kindling: implications for mechanisms of action in affective illness, Epilepsia, 25 (1984) 234-239.
21. Racine, R.J., Modification of seizure activity by electrical activity. II. Motor seizure, Electroenceph. Clin. Neurophysiol., 32 (1972) 281-294.
22. Rosen, J.B., Kim, S.Y. and Post, R.M., Differential regional and time course increases in thyrotropin-releasing hormone, neuropeptide Y and enkephalin mRNAs following an amygdala kindled seizure, Mol. Brain Res., 27 (1994) 71-80.
23. Somogyi, P., Hodgson, A.J., Smith, A.D., Nunzi, M.G., Gorio, A. and Wu, J.Y., Different populations of GABAnergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or choecystokinin-immunoreactive material, J. Neurosci., 4 (1984) 2590-2603.
24. Tomasson, K., Winokur, G. and Pfohl, B., Failed and short seizures associated with prior electroconvulsive therapy, Eur. Arch. Psychiatry Clin. Neurosci., 241 (1992) 307-313.
25. Vezzani, A., Wu, H.Q., Moneta, E. and Samanin, R., Role of the N-methyl-D-aspartate-type receptors in the development and maintenance of hippocampal kindling in rats, Neurosci. Lett., 87 (1988) 63-68.
26. Whitefield, H.J., Brady, L.S., Smith, M.A., Mamalaki, E., Fox, R.J. and Herkenham, M., Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol, Cell. Mol. Neurobiol., 10 (1990) 145-157.
27. Wu, X.R. and Lin, P.X., Effects of cholecystokinin octapeptide on genetically determined seizure susceptibility, Chin. Med. J. (Engl.), 105 (1992) 110-115.
28. Yamamoto, Y., Itano, T., Miyamoto, O., Tokuda, M., Matsui, H., Janjua, N.A., Suwaki, H., Okada, Y., Negi, T., Murakami, T.H. et al., Effect of ceruletide on epileptogenesis in amygdaloid kindled rats, Brain Res., 630 (1993) 353-356.
29. Zetler, G., Anticonvulsant effects of caerulein, cholecystokinin octapeptide compared with those of diazepam, Eur. J. Pharmacol., 65 (1980) 297-300.
30. Zetler, G., Anticonvulsant effects of caerulei and cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid, Neurosci. Lett., 24 (1981) 175-179.
31. Zetler, G., Atagonism of cholecystokinin-like peptides by opioid peptides, morphine or tetrodotoxin, Eur. J. Pharmacol., 60 (1979) 67-77.
32. Zetler, G., Caerulein and cholecystokinin octapeptide (CCK-8): sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788, Neurosci. Lett., 28 (1982) 287-290.
33. Zhang, L.X., Wu, M. and Han, J.S., Suppression of audiogenic epileptic seizures by intracerebral injection of a CCK gene vector, NeuroReport, 3 (1992) 700-702.
34. Zhang, L.X., Zhou, Y., Du, Y. and Han, J.S., Effect of CCK-8 on audiogenic epileptic seizure in P77PMC rats, Neuropeptides, 25 (1993) 73-76.
35. Zhou, Y., Sun, Y., Zhang, Z. and Han, J., Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine, NeuroReport, 3 (1992) 1121-1123.